Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: A systematic review of randomized trials

2004 Bierbaum, 1999, An Analysis of Blood Management in Patients Having a Total Hip or Knee Arthroplasty, J Bone Jt Surg, 81, 2, 10.2106/00004623-199901000-00002 R. Carver, R. Cooper: Anaesthesia for joint replacement surgery. AnaesthesiaUK. 2005. Sehat, 2004, Hidden blood loss following hip and knee arthroplasty, J Bone Jt Surg (Br), 86B, 561, 10.1302/0301-620X.86B4.14508 Rao, 2007, Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes, Eur Heart J, 28, 1193, 10.1093/eurheartj/ehm019 Yang, 2004, The Implications of Blood Transfusions for Patients With Non-ST – Segment Elevation Acute Coronary Syndromes, J Am Coll Cardiol, 46, 1490, 10.1016/j.jacc.2005.06.072 2007 Mannucci, 1998, Hemostatic Drugs, N Engl J Med, 339, 245, 10.1056/NEJM199807233390407 Prentice, 1980, Basis of Antifibrinolytic Therapy, J Clin Pathol Suppl, 14, 35, 10.1136/jcp.s3-14.1.35 Trasylol Product Monograph, Bayer Pharmaceuticals; 2006 Mangano, 2006, The Risk Associated with Aprotinin in Cardiac Surgery, N Engl J Med, 354, 353, 10.1056/NEJMoa051379 2006 Zufferey, 2006, Do Antifibrinolytics Reduce Allogeneic Blood Transfusion in Orthopedic Surgery?, Anesthesiology, 2105, 1034, 10.1097/00000542-200611000-00026 Jadad, 1996, Assessing the Quality of Reports of Randomized Clinical Trials: Is Blinding Necessary?, Control Clin Trials, 17, 1, 10.1016/0197-2456(95)00134-4 Cohen, 1988 Xing, 2008, Has the Incidence of deep vein thrombosis in patients undergoing total hip/knee arthroplasty changed over time? A systematic review of randomized controlled trials, Thromb Res, 10.1016/j.thromres.2008.05.005 Review Manager (RevMan) Version 4.2.8 for Windows; Oxford, England: The Cochrane Collaboration, 2005. Cvachovec, 2001, Aprotinin (antilysin spofa) - its effect on the reduction of haemorrhage in post-operative period in patients with THA, Acta Chir Orthop Traumatol Cechoslov, 68, 311 Ketterl, 1982, The Effect of Aprotinin on the Blood Lactate Level, The Platelet Function and on Parameters of Coagulation Following Total Hip Replacement, Haemostasis, 12, 68 Haas, 1983, The Effect of Aprotinin on Platelet Function, Blood Coagulation and Blood Lactate Level in Total Hip Replacement – A Double Blind Clinical Trial, Thromb Haemost, 50 Ozay, 1995, Aprotinin infusion during major orthopaedic surgery, Br J Anaesth, 74, A.201 Capdevila, 1998, Aprotinin Decreases Blood Loss and Homologous Transfusions in Patients Undergoing Major Orthopedic Surgery, Anesthesiology, 88, 50, 10.1097/00000542-199801000-00010 Samama, 2002, Aprotinin Versus Placebo in Major Orthopedic Surgery: A Randomized, Double-Blinded, Dose-Ranging Study, Anesth Analg, 95, 287, 10.1213/00000539-200208000-00005 Amar, 2003, Antifibrinolytic Therapy and Perioperative Blood Loss in Cancer Patients Undergoing Major Orthopedic Surgery, Anesthesiology, 98, 337, 10.1097/00000542-200302000-00011 Murkin, 1995, Aprotinin Decreases Blood Loss in Patients Undergoing Revision or Bilateral Total Hip Arthroplasty, Anesth Analg, 80, 343 Shiga, 2005, Aprotinin in Major Orthopedic Surgery: A Systematic Review of Randomized Controlled Trials, Anesth Analg, 101, 1602, 10.1213/01.ANE.0000180767.50529.45 Jeserschek, 2003, Reduction of blood loss using high-dose aprotinin in major orthopaedic surgery, J Bone Jt Surg [Br], 85B, 174, 10.1302/0301-620X.85B2.13303 Zohar, 2001, A comparative study of the postoperative allogeneic blood-sparing effects of tranexamic acid and of desmopressin after total knee replacement, Transfusion, 41, 1285, 10.1046/j.1537-2995.2001.41101285.x K. Ido: Reduction of blood loss using tranexamic acid in total knee and hip arthroplasties. Kasper, 1998, A Retrospective study of the effects of small-dose aprotinin on blood loss and transfusion needs during total hip arthroplasty, Eur J Anaesthesiol, 15, 669, 10.1097/00003643-199811000-00008 Benoni, 1995, Does Tranexamic Acid Reduce Blood Loss in Knee Arthroplasty?, Am J Knee Surg, 8, 88 Singbartl, 2001, Adjunct aprotinin administration is at least a cost-neutral blood saving measure in infective knee revision surgery, Curr Opin Clin Exp Res, 3, 146 Hynes, 2003, The use of tranexamic acid to reduce blood loss during total knee arthroplasty, The Knee, 10, 375, 10.1016/S0968-0160(03)00044-9 Kinzel, 2005, The effect of aprotinin on blood loss in bilateral total knee arthroplasty, The Knee, 12, 107, 10.1016/j.knee.2004.03.009 Singbartl, 2001, Transfusion-Related Cost of Adjunct Aprotinin Application in One-Step Infected Hip Revision Arthroplasty – Cost-Minimizing Analysis, Infus Ther Transfus Med, 28, 74 Yamasaki, 2005, Tranexamic Acid Reduces Postoperative Blood Loss in Cementless Total Hip Arthroplasty, J Bone Jt Surg Am, 87, 766, 10.2106/JBJS.D.02046 McCarthy, 1994, Aprotinin for Prophylaxis of Blood Loss, Ann Pharmacother, 28, 1246 Coats, 2005, Antifibrinolytic agents in traumatic haemorrhage, Indian J Pharmacol, 37, 3, 10.4103/0253-7613.13846 Hynes, 2005, The use of tranexamic acid to reduce blood loss during total hip arthroplasty: an observational study, Ann R Coll Surg Engl, 87, 99, 10.1308/147870805X28118 C. Little: Effect of tranexamic acid in total knee arthroplasty – pilot study. Unpublished. Engel, 2001, Regional Hemostatic Status and Blood Requirements After Total Knee Arthroplasty With and Without Tranexamic Acid or Aprotinin, Anesth Analg, 92, 775, 10.1213/00000539-200103000-00041 Ellis, 2004, Oral tranexamic acid in total knee replacement: results of a randomized study, Vox Sanguinis, 87, S50 D'Ambrosio, 1999, Reducing perioperative blood loss in patients undergoing total hip arthroplasty, Int J Artfi Organs, 22, 47, 10.1177/039139889902200110 Duquenne, 1999, Tranexamic Acid Reduces Postoperative Blood Losses Associated with Elective Total Hip Replacement, J Bone Jt Surg (Br), 81B, 233 Langdown, 2000, Aprotinin (Trasylol) Does Not Reduce Bleeding in Primary Total Hip Arthroplasty, J Arthroplast, 15, 1009, 10.1054/arth.2000.8102 Yamasaki, 2004, Tranexamic acid reduces blood loss after cementless total hip arthroplasty – prospective randomized study in 40 cases, Int Orthop, 28, 69, 10.1007/s00264-003-0511-4 Murkin, 2000, Aprotinin Decreases Exposure to Allogeneic Blood During Primary Unilateral Total Hip Replacement, J Bone Joint Surg Am, 82, 675, 10.2106/00004623-200005000-00008 Ray, 2005, Aprotinin and epsilon aminocaproic acid are effective in reducing blood loss after primary total hip arthroplasty – a prospective randomized double-blind placebo-controlled study, J Thromb Haemost, 3, 1421, 10.1111/j.1538-7836.2005.01457.x Benoni, 1996, Fibrinolytic Inhibition with Tranexamic Acid Reduces Blood Loss and Blood Transfusion After Knee Arthroplasty, J. Bone Jt Surg [Br], 78B, 434, 10.1302/0301-620X.78B3.0780434 Molloy, 2007, Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement – A Prospective, Randomised Controlled Trial, J Bone Jt Surg (Br), 89-B, 306, 10.1302/0301-620X.89B3.17565 Benoni, 2000, Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty, Acta Orthop Scand, 71, 250, 10.1080/000164700317411834 Ekbäck, 2000, Tranexamic Acid Reduces Blood Loss in Total Hip Replacement Surgery, Anesth Analg, 91, 1124, 10.1213/00000539-200011000-00014 Lemay, 2004, Tranexamic acid reduces the need for allogenic red blood cell transfusions in patients undergoing total hip replacement, Can J Anesth, 51, 31, 10.1007/BF03018543 Veien, 2002, Tranexamic acid given intraoperatively reduces blood loss after total knee replacement: a randomized, controlled study, Acta Anaesthesiol Scand, 46, 1206, 10.1034/j.1399-6576.2002.461007.x Johansson, 2005, Tranexamic acid in total hip arthroplasty saves blood and money, Acta Orthop, 76, 314, 10.1080/00016470510030751 Husted, 2003, Tranexamic acid reduces blood loss and blood transfusions in primary total hip arthroplasty, Acta Orthop Scand, 74, 665, 10.1080/00016470310018171 Benoni, 2001, Blood conservation with tranexamic acid in total hip arthroplasty, Acta Orthop Scand, 72, 442, 10.1080/000164701753532754 Hiippala, 1995, Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with total knee arthroplasty, Br J Anaesth, 74, 534, 10.1093/bja/74.5.534 Garneti, 2004, Bone Bleeding During Total Hip Arthroplasty After Administration of Tranexamic Acid, J Arthroplast, 19, 488, 10.1016/j.arth.2003.12.073 Good, 2003, Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement, Br J Anaesth, 90, 596, 10.1093/bja/aeg111 Hiippala, 1997, Tranexamic Acid Radically Decreases Blood Loss and Transfusions Associated with Total Knee Arthroplasty, Anesth Analg, 84, 839, 10.1213/00000539-199704000-00026 Jansen, 1999, Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty, Br J Anaesth, 83, 596, 10.1093/bja/83.4.596 Zohar, 2004, The Postoperative Blood-Sparing Efficacy of Oral Versus Intravenous Tranexamic Acid After Total Knee Replacement, Anesth Analg, 99, 1670 Tanaka, 2001, Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee, J Bone Joint Surg [Br], 83B, 702, 10.1302/0301-620X.83B5.11745 Niskanen, 2005, Tranexamic acid reduces blood loss in cemented hip arthroplasty, Acta Orthop, 26, 829, 10.1080/17453670510045444 Orpen, 2006, Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: A prospective randomized controlled trial of 29 patients, The Knee, 13, 106, 10.1016/j.knee.2005.11.001 Janssens, 1994, High Dose Aprotinin Reduces Blood Loss in Patients Undergoing Total Hip Replacement Surgery, Anesthesiology, 80, 23, 10.1097/00000542-199401000-00007 Thorpe, 1994, Use of aprotinin in knee replacement surgery, Br J Anaesth, 73, 408, 10.1093/bja/73.3.408 Compostella, 1997, High dose aprotinin in elective total HIP replacement surgery: Effects on bleeding and renal function, Br J Anaesth, 78, 66 Hayes, 1996, The Efficacy of Single-Dose Aprotinin 2 Million KIU in Reducing Blood Loss and Its Impact on the Incidence of Deep Venous Thrombosis in Patients Undergoing Total Hip Replacement Surgery, J Clin Anesth, 8, 357, 10.1016/0952-8180(96)00080-3 Petsatodis, 2006, Does Aprotinin Reduce Blood Loss in Total Hip Arthroplasty?, Proquest Nurs J, 29, 75 Harley, 2002, The effect of epsilon aminocaproic acid on blood loss in patients who undergo primary total hip replacement: a pilot study, Can J Surg, 45, 185 Camarasa, 2006, Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial, Br J Anaesth, 96, 576, 10.1093/bja/ael057 Mackinnon, 2000, A spreadsheet for the calculation of comprehensive statistics for the assessment of diagnostic tests and inter-rater agreement, Comput Biol Med, 30, 127, 10.1016/S0010-4825(00)00006-8 Mercuriali, 1999, Transfusion risks and limitations, Minerva Anestesiol, 65, 286 Nielsen, 1995, Detrimental effects of perioperative blood transfusion, Br J Surg, 82, 582, 10.1002/bjs.1800820505 Sehat, 2005, How much blood is really lost in total knee arthroplasty? Correct blood management should take hidden loss into account, The Knee, 7, 151, 10.1016/S0968-0160(00)00047-8 Schneeweiss, 2008, Aprotinin during Coronary-Artery Bypass Grafting and Risk of Death, N Engl J Med, 358, 771, 10.1056/NEJMoa0707571 Fergusson, 2008, A Comparison of Aprotinin and Lysine Analogues in High-Risk Cardiac Surgery, N Engl J Med, 358, 2319, 10.1056/NEJMoa0802395 Ray, 2008, The Aprotinin Story – Is BART the Final Chapter?, N Engl J Med, 358, 2398, 10.1056/NEJMe0803514